AdventHealth Cancer Institute is Among the First in the World to Offer a New Phase II Clinical Trial of a Novel, Customized Precision Immunotherapy for Patients with High-risk Muscle-invasive Urothelial Carcinoma
Under the leadership of principal investigator Guru Sonpavde, MD, AdventHealth Cancer Institute (AHCI) is among the first sites in the world and the only in Florida to offer a new, global Phase II...